Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
MorphoSys (NASDAQ:MOR) reported its Q4 earnings results on Wednesday, March 13, 2024 at 04:00 PM.
Here's what investors need to know about the announcement.
MorphoSys beat estimated earnings by 267.0%, reporting an EPS of $0.33 versus an estimate of $0.09.
Revenue was down $19.78 million from the same period last year.
Last quarter the company beat on EPS by $0.87 which was followed by a 11.0% drop in the share price the next day.
Here's a look at MorphoSys's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -1.82 | -1.88 | -0.53 | |
EPS Actual | -0.95 | -0.59 | -0.35 | 2.28 |
Revenue Estimate | 59.33M | 58.46M | 49.51M | 80.68M |
Revenue Actual | 69.44M | 57.98M | 66.86M | 83.29M |
To track all earnings releases for MorphoSys visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: MOR